Navigation Links
Jazz Pharmaceuticals Announces Stockholder Vote in Favor of Transaction With Azur Pharma Limted
Date:12/12/2011

rated company, we look forward to building on our diverse portfolio of commercial products, strong balance sheet and efficient corporate structure for continued growth into the future."

About Jazz Pharmaceuticals
Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet needs in neurology and psychiatry. For further information, see http://www.jazzpharmaceuticals.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995
This press release contains forward-looking statements, including, but not limited to, statements related to the anticipated consummation of the business combination transaction between Jazz Pharmaceuticals and Azur Pharma and the timing and benefits thereof, the combined company's future financial results and growth potential and other statements that are not historical facts. These forward-looking statements are based on Jazz Pharmaceuticals' current expectations and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to Jazz Pharmaceuticals' ability to complete the transaction on the proposed terms and schedule; risks associated with business combination transactions, such as the risk that the businesses will not be integrated successfully or that such integration may be more difficult, time-consuming or costly than expected; risks related to future opportunities and plans for the combined company, including uncertainty of the expected financial performance and results of the combined company following completion of th
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... -- On September 25 to 26, 2014, ... and manufacturing - MEDTEC China  - will mark its ... Convention Center, bringing together close to 300 leading global ... latest medical-grade raw materials, parts and processing technologies. ... free visitor pre-registration to be completed. To date, more ...
(Date:9/16/2014)... , Sept. 16, 2014 Northwest Biotherapeutics (NASDAQ: ... developing DCVax® personalized immune therapies for solid tumor cancers, ... to receive formal designation as a "Promising Innovative Medicine" ... (EAMS) launched in the UK in April 2014.  A ... for early access approval under the EAMS.  ...
(Date:9/16/2014)... 2014  Synereca Pharmaceutics, Inc. (SPI), a ... drugs that restore or increase the effectiveness ... million convertible debt financing. Accele Venture Partners, ... Accele Biopharma, Inc., led the financing with ... private not-for-profit corporation focused on growing innovative ...
Breaking Medicine Technology:MEDTEC China 2014: Seven Highlights Not to Miss! 2MEDTEC China 2014: Seven Highlights Not to Miss! 3MEDTEC China 2014: Seven Highlights Not to Miss! 4NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 2NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 3NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 4NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 5Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 2Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 3Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 4
... France, July 10 Ipsogen SA,(Alternext: ALIPS) today reported ... Therapy of Early Breast Cancer indicated for the first,time ... adjunct to the,histological grade. These new guidelines, published online ... European and US experts on,early breast cancer treatment that ...
... , KENILWORTH, N.J., July 9 Schering-Plough Corporation (NYSE: ... the company,s country operation in Japan, has received marketing ... for the treatment of bronchial asthma in adults.(1) , ... of the ASMANEX TWISTHALER in Japan," said Thomas P. ...
Cached Medicine Technology:Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting on the Primary Treatment of Early Breast Cancer 2Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting on the Primary Treatment of Early Breast Cancer 3ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients 2ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients 3ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients 4
(Date:9/16/2014)... the right balance of nitrogen, phosphorus and potassium is ... State University study finds. , A review of data ... other regions showed that high yields were linked to ... nutrients at specific ratios - nitrogen and phosphorus at ... a ratio of 1-to-1. These nutrient uptake ratios were ...
(Date:9/16/2014)... PA (PRWEB) September 16, 2014 AcousticSheep ... are preparing to launch RunPhones® Wireless, their latest version ... inside a sport-style headband for active people seeking a ... sport headphones on the market and will be ... new RunPhones® Wireless has all of the same great ...
(Date:9/16/2014)... Tara Haelle HealthDay ... -- About 14.5 million U.S. cancer survivors are alive ... American Association for Cancer Research reported Tuesday. These ... include nearly 380,000 survivors of childhood cancer, according to ... in prevention, identification, research and treatment of cancer and ...
(Date:9/16/2014)... September 16, 2014 Novatus, a leading ... new office in London, UK, and appointed Jim Curran ... Europe, the expansion will allow Novatus to target growing ... European customers. , “Novatus is excited ... London is an ideal location to establish our European ...
(Date:9/16/2014)... DC September 16, 2014 The ... coherence tomography (OCT) in primary percutaneous coronary ... annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. ... TCT is the world,s premier educational meeting ... OCT uses light emitted from an intravascular ...
Breaking Medicine News(10 mins):Health News:Boosting global corn yields depends on improving nutrient balance 2Health News:Boosting global corn yields depends on improving nutrient balance 3Health News:RunPhones® Prepares to Launch Their New Highly Anticipated Wireless Headphones 2Health News:RunPhones® Prepares to Launch Their New Highly Anticipated Wireless Headphones 3Health News:Targeted Drugs Among Successes Against Cancer, Says New Report 2Health News:Targeted Drugs Among Successes Against Cancer, Says New Report 3Health News:Targeted Drugs Among Successes Against Cancer, Says New Report 4Health News:Novatus Expands European Operations with a New Office in London 2Health News:Results of OCT STEMI trial reported at TCT 2014 2
... to lead Diabetes Sales, Managed Care and Government ... ... Novo Nordisk, a,healthcare company with an 85-year history of innovation ... Pamela Harris as,vice president for Diabetes Sales, Managed Care and ...
... Two-Week Eye Health Program,in Mandalay, NEW YORK, Feb. ... and the Mandalay Eye and ENT Hospital, ORBIS,International, a ... to Myanmar to conduct its ninth Flying Eye,Hospital program ... February,25 to March 7, 2008., Working together with ...
... drive to digitize data creates need for 99.999% ... ... virtually all healthcare,record keeping and patient care functions converting to ... grade" servers that provide the extreme reliability healthcare,practices need to ...
... rarely detected before it has grown large enough to impair ... disease to fight, especially since chemotherapy is not very effective. ... Faingold may open the door for very promising new treatment ... the cover of the February 2008 issue of Clinical Cancer ...
... Frank E. Staggers, Sr.,M.D. of Oakland, Calif., is a ... Excellence in Volunteerism. Presented by the American Medical,Association (AMA) ... commitment to volunteer medical care to those without access,to ... the award in,association with the Pfizer Medical Humanities Initiative., ...
... Joyce D. Kirkland Essien,M.D., M.B.A., of Atlanta, is ... Presented by the American Medical Association (AMA),Foundation, the award ... the U.S. The AMA Foundation presents the award in,association ... will be presented on Monday, March 31st, at the ...
Cached Medicine News:Health News:Novo Nordisk Consolidates U.S. Diabetes Sales Leadership Under Single Vice President 2Health News:ORBIS International's Flying Eye Hospital Returns to Myanmar 2Health News:Stratus Medical Grade Servers Deliver 24/7 Online Information Access and Application Availability 2Health News:Stratus Medical Grade Servers Deliver 24/7 Online Information Access and Application Availability 3Health News:HSP90: New point of view on melanoma of the eye, at the MUHC 2Health News:AMA Foundation Honors Oakland, California Physician for Volunteerism 2Health News:AMA Foundation Honors Atlanta Physician for Increasing Access to Health Care in the U.S. 2
... System is a point-of-care system designed for ... referred to as Platelet Rich Plasma - ... a small sample of blood. The Symphony ... factors, which are found in the platelets. ...
... Dual Imaging Color Module Leica combines precision microscopy ... important and necessary patient data can be displayed ... optical platform on the Leica OH3, OHS1, MS3 ... highest brightness, contrast >300:1, true color and resolution ...
... Headlight mounted micro video camera has ... pictures in areas otherwise invisible to all ... capabilities. The system may be used for ... eliminating crowding of the sterile area and ...
... DXC-S500 consists of 2-piece body, one is CHU ... and built-in Peltier cooling devices, the other is ... monitor. CCU incorporates IEEE1394 interface for direct connection ... card slot for storing images into memory stick ...
Medicine Products: